HIMA (US Health Industry Manufacturers Association) orders report on medtech in managed care:
This article was originally published in Clinica
The US Health Industry Manufacturers Association (HIMA) has chosen RAND Health, a private, not-for-profit research institution, to conduct a study on the adoption of new medical technology in managed care settings. The study will identify how managed care firms currently review and pay for technology, as well as how device manufacturers participate and prepare for this process. Its aims include finding ways of improving the process by which new medical technologies are developed, evaluated, and adopted or rejected for coverage.
You may also be interested in...
Arcadia prohibited from arguing against Advantice’s appeal of National Advertising Division decision that Kerasal Fungal Nail Renewal ad claims weren’t supported. Arcadia violated confidentiality rule by publicizing NAD decision before the review was officially closed.
The C-suite leaders schemed to falsely record shipments of unwanted products to distributors as sales so the company could meet revenue projections, the government charged.
Gallium has been approved as a diagnostic agent by the US agency to help early detection of prostate cancer spread in patients who qualify for treatment with surgery or radiation therapy.